By Haley Mickey
Scientists in Britain have discovered a protein which may be used as a target for a new tuberculosis vaccine. This discovery from Imperial College London could be a first step in the eradication of tuberculosis because though a TB vaccine currently exists — the Bacillus Calmette-Guerin, or BCG vaccine — it is not highly effective. Ajit Lalvani a professor and chair in Infection Diseases at Imperial College London who led the research, said even though most of the world’s population has been vaccinated against the disease with BCG, nine million new cases are reported every year.
Leave a Reply